As of 2026-04-05, the Relative Valuation of Qiagen NV (QGEN) is 48.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.03 USD, the upside of Qiagen NV based on Relative Valuation is 19.1%.
The range of the Relative Valuation is 44.74 - 53.81 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 26.1x | 24.1x |
| Forward P/E multiples | 20.3x - 23.6x | 21.8x |
| Fair Price | 44.74 - 53.81 | 48.87 |
| Upside | 9.0% - 31.2% | 19.1% |
| Date | P/E |
| 2026-04-02 | 19.90 |
| 2026-04-01 | 19.58 |
| 2026-03-31 | 19.42 |
| 2026-03-30 | 19.07 |
| 2026-03-27 | 18.95 |
| 2026-03-26 | 19.26 |
| 2026-03-25 | 19.71 |
| 2026-03-24 | 19.29 |
| 2026-03-23 | 19.15 |
| 2026-03-20 | 19.37 |
| 2026-03-19 | 19.72 |
| 2026-03-18 | 19.62 |
| 2026-03-17 | 20.15 |
| 2026-03-16 | 19.85 |
| 2026-03-13 | 19.69 |
| 2026-03-12 | 19.94 |
| 2026-03-11 | 19.99 |
| 2026-03-10 | 20.86 |
| 2026-03-09 | 21.02 |
| 2026-03-06 | 21.61 |
| 2026-03-05 | 22.52 |
| 2026-03-04 | 22.74 |
| 2026-03-03 | 23.11 |
| 2026-03-02 | 23.68 |
| 2026-02-27 | 24.15 |
| 2026-02-26 | 23.80 |
| 2026-02-25 | 23.58 |
| 2026-02-24 | 23.52 |
| 2026-02-23 | 23.01 |
| 2026-02-20 | 23.56 |
| 2026-02-19 | 23.44 |
| 2026-02-18 | 23.78 |
| 2026-02-17 | 23.65 |
| 2026-02-13 | 24.45 |
| 2026-02-12 | 24.66 |
| 2026-02-11 | 24.76 |
| 2026-02-10 | 24.77 |
| 2026-02-09 | 24.63 |
| 2026-02-06 | 24.71 |
| 2026-02-05 | 24.85 |
| 2026-02-04 | 25.08 |
| 2026-02-03 | 25.17 |
| 2026-02-02 | 25.31 |
| 2026-01-30 | 26.03 |
| 2026-01-29 | 26.05 |
| 2026-01-28 | 26.19 |
| 2026-01-27 | 26.30 |
| 2026-01-26 | 26.30 |
| 2026-01-23 | 26.98 |
| 2026-01-22 | 26.31 |